Media
Back
Professor William Bonfield is Professor of Medical Materials in the Department of Materials Science and Metallurgy, at the University of Cambridge, UK. His major research interests are in bioceramics, polymers, and composites for bone replacement, biomechanics and tissue engineering. He is also Director of the Pfizer Institute for Pharmaceutical Materials Science, and Cambridge Director of the Cambridge-Massachusetts Institute Interdisciplinary Research Cluster in Biomaterials and Tissue Engineering.
Professor Bonfield has been internationally recognised for his pioneering contributions to biomaterials, with awards including the Kelvin Medal, The Royal Society Armourers and Brasiers' Company Medal, The Institute of Materials Griffith Medal, The European Society for Biomaterials George Winter Award, and the Acta Metallurgica J. Herbert Holloman Award. In 1998 Professor Bonfield was appointed a CBE for his services to healthcare and to materials science.
Medical implants are part of a general clinical strategy to restore function of damage tissue and to relieve pain. For example, joint replacement surgery has become a major activity on a global scale for the treatment of arthritic hips and knees, providing relief from pain and restoration of mobility for about 1 million patients per year. In parallel, the treatment of arterial disease, initially with vascular grafts and now increasingly with balloon angioplasty, saves many thousands of lives each year. Such clinical examples depend critically on the associated medical devices, and the biomaterials selected. The basis for these procedures are discussed and the prospects for optimisation reviewed. While originally based on relatively bioinert materials, derived from engineering practice, the current international focus is on the innovation of novel biomaterials based on the biological template, with the prospect of extended prostheses' lifetimes for patients, and associated technology opportunities for industrial companies.
Members of the press and interested parties are cordially invited to attend. For further enquiries, please contact Ms Hailey Lam of Faculty of Engineering at 2859 2438.
Professor of Medical Materials of the University of Cambridge to deliver lecture at HKU
26 Nov 2002
Professor William Bonfield of the University of Cambridge is to deliver a William Mong Distinguished Lecture entitled Can Medical Implants be Improved? at 5:30pm on Thursday, November 28, 2002 at Lecture Theatre A, Chow Yei Ching Building, the University of Hong Kong.
Professor William Bonfield is Professor of Medical Materials in the Department of Materials Science and Metallurgy, at the University of Cambridge, UK. His major research interests are in bioceramics, polymers, and composites for bone replacement, biomechanics and tissue engineering. He is also Director of the Pfizer Institute for Pharmaceutical Materials Science, and Cambridge Director of the Cambridge-Massachusetts Institute Interdisciplinary Research Cluster in Biomaterials and Tissue Engineering.
Professor Bonfield has been internationally recognised for his pioneering contributions to biomaterials, with awards including the Kelvin Medal, The Royal Society Armourers and Brasiers' Company Medal, The Institute of Materials Griffith Medal, The European Society for Biomaterials George Winter Award, and the Acta Metallurgica J. Herbert Holloman Award. In 1998 Professor Bonfield was appointed a CBE for his services to healthcare and to materials science.
Medical implants are part of a general clinical strategy to restore function of damage tissue and to relieve pain. For example, joint replacement surgery has become a major activity on a global scale for the treatment of arthritic hips and knees, providing relief from pain and restoration of mobility for about 1 million patients per year. In parallel, the treatment of arterial disease, initially with vascular grafts and now increasingly with balloon angioplasty, saves many thousands of lives each year. Such clinical examples depend critically on the associated medical devices, and the biomaterials selected. The basis for these procedures are discussed and the prospects for optimisation reviewed. While originally based on relatively bioinert materials, derived from engineering practice, the current international focus is on the innovation of novel biomaterials based on the biological template, with the prospect of extended prostheses' lifetimes for patients, and associated technology opportunities for industrial companies.
Members of the press and interested parties are cordially invited to attend. For further enquiries, please contact Ms Hailey Lam of Faculty of Engineering at 2859 2438.
Facebook 
HKU IOS App 
HKU Android App 
Social Media and Apps